A citation-based method for searching scientific literature

Andrea Porzionato, Veronica Macchi, Marcin Rucinski, Ludwik K Malendowicz, Raffaele De Caro. Int Rev Cell Mol Biol 2010
Times Cited: 14







List of co-cited articles
28 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity




Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones.
Aldo Clerico, Alberto Giannoni, Simona Vittorini, Claudio Passino. Am J Physiol Heart Circ Physiol 2011
126
21

Plasma concentrations of brain natriuretic peptide in patients with acute ischemic stroke.
Kazuhiko Nakagawa, Takekane Yamaguchi, Mitsuru Seida, Shimpei Yamada, Shogo Imae, Yoji Tanaka, Kiyotaka Yamamoto, Kikuo Ohno. Cerebrovasc Dis 2005
85
21


Physiological, pathological, pharmacological, biochemical and hematological factors affecting BNP and NT-proBNP.
Cynthia M Balion, Pasqualina Santaguida, Robert McKelvie, Stephen A Hill, Matthew J McQueen, Andrew Worster, Parminder S Raina. Clin Biochem 2008
39
14



Biology of the natriuretic peptides.
Abelardo Martinez-Rumayor, A Mark Richards, John C Burnett, James L Januzzi. Am J Cardiol 2008
144
14

Determinants of plasma levels of brain natriuretic peptide after acute ischemic stroke or TIA.
Emanuele Di Angelantonio, Stefano De Castro, Danilo Toni, Maria Luisa Sacchetti, Francesco Biraschi, Massimiliano Prencipe, Marco Fiorelli. J Neurol Sci 2007
37
14

Natriuretic peptides.
E R Levin, D G Gardner, W K Samson. N Engl J Med 1998
14

Neuroendocrine changes in patients with acute space occupying ischaemic stroke.
S Schwarz, S Schwab, K Klinga, C Maser-Gluth, M Bettendorf. J Neurol Neurosurg Psychiatry 2003
47
14


Cardiac sequelae of acute stroke.
M G Myers, J W Norris, V C Hachinski, M E Weingert, M J Sole. Stroke 1982
167
14

Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers.
Joan Montaner, Mila Perea-Gainza, Pilar Delgado, Marc Ribó, Pilar Chacón, Anna Rosell, Manolo Quintana, Mauricio E Palacios, Carlos A Molina, José Alvarez-Sabín. Stroke 2008
203
14

Natriuretic peptides and mortality after stroke.
A M Mäkikallio, T H Mäkikallio, J T Korpelainen, O Vuolteenaho, J M Tapanainen, K Ylitalo, K A Sotaniemi, H V Huikuri, V V Myllylä. Stroke 2005
114
14


A new natriuretic peptide in porcine brain.
T Sudoh, K Kangawa, N Minamino, H Matsuo. Nature 1988
14

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.
Scott D Solomon, Michael Zile, Burkert Pieske, Adriaan Voors, Amil Shah, Elisabeth Kraigher-Krainer, Victor Shi, Toni Bransford, Madoka Takeuchi, Jianjian Gong,[...]. Lancet 2012
656
14

Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNi).
Jessie Gu, Adele Noe, Priya Chandra, Suliman Al-Fayoumi, Monica Ligueros-Saylan, Ramesh Sarangapani, Suzanne Maahs, Gary Ksander, Dean F Rigel, Arco Y Jeng,[...]. J Clin Pharmacol 2010
294
14

Angiotensin-neprilysin inhibition versus enalapril in heart failure.
John J V McMurray, Milton Packer, Akshay S Desai, Jianjian Gong, Martin P Lefkowitz, Adel R Rizkala, Jean L Rouleau, Victor C Shi, Scott D Solomon, Karl Swedberg,[...]. N Engl J Med 2014
14


Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide.
S Suga, K Nakao, K Hosoda, M Mukoyama, Y Ogawa, G Shirakami, H Arai, Y Saito, Y Kambayashi, K Inouye. Endocrinology 1992
651
14


C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain.
T Sudoh, N Minamino, K Kangawa, H Matsuo. Biochem Biophys Res Commun 1990
930
14

C-type natriuretic peptide (CNP) in rats and humans.
Y Komatsu, K Nakao, S Suga, Y Ogawa, M Mukoyama, H Arai, G Shirakami, K Hosoda, O Nakagawa, N Hama. Endocrinology 1991
306
14

Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions.
Lincoln R Potter, Sarah Abbey-Hosch, Deborah M Dickey. Endocr Rev 2006
657
14

Human brain natriuretic peptide-like immunoreactivity in human brain.
K Takahashi, K Totsune, M Sone, M Ohneda, O Murakami, K Itoi, T Mouri. Peptides 1992
102
14

Cilostazol improves cognitive function in mice by increasing the production of insulin-like growth factor-I in the hippocampus.
Juan Zhao, Naoaki Harada, Hiroki Kurihara, Naomi Nakagata, Kenji Okajima. Neuropharmacology 2010
22
7

Cyclic nucleotide phosphodiesterase 3A-deficient mice as a model of female infertility.
Silvia Masciarelli, Kathleen Horner, Chengyu Liu, Sun Hee Park, Mary Hinckley, Steven Hockman, Taku Nedachi, Catherine Jin, Marco Conti, Vincent Manganiello. J Clin Invest 2004
162
7

Phosphoinositide 3-kinasegamma (PI3Kgamma) controls L-type calcium current (ICa,L) through its positive modulation of type-3 phosphodiesterase (PDE3).
Andrea Marcantoni, Renzo Cesare Levi, Maria Pia Gallo, Emilio Hirsch, Giuseppe Alloatti. J Cell Physiol 2006
21
7

Adenylyl cyclase/cAMP-PKA-mediated phosphorylation of basal L-type Ca(2+) channels in mouse embryonic ventricular myocytes.
Xisheng Yan, Shijun Gao, Ming Tang, Jiaoya Xi, Linlin Gao, Minjie Zhu, Hongyan Luo, Xinwu Hu, Yunjie Zheng, Jürgen Hescheler,[...]. Cell Calcium 2011
10
10

A new nonhydrolyzable reactive cGMP analogue, (Rp)-guanosine-3',5'-cyclic-S-(4-bromo-2,3-dioxobutyl)monophosphorothioate, which targets the cGMP binding site of human platelet PDE3A.
Su H Hung, Andy H Liu, Robin A Pixley, Penelope Francis, LaTeeka D Williams, Christopher M Matsko, Karine D Barnes, Sharmila Sivendran, Roberta F Colman, Robert W Colman. Bioorg Chem 2008
3
33

Phosphorylation of PDE3B by phosphatidylinositol 3-kinase associated with the insulin receptor.
C M Rondinone, E Carvalho, T Rahn, V C Manganiello, E Degerman, U P Smith. J Biol Chem 2000
57
7

Natriuretic peptides like NO facilitate cardiac vagal neurotransmission and bradycardia via a cGMP pathway.
N Herring, J A Zaman, D J Paterson. Am J Physiol Heart Circ Physiol 2001
58
7

Phosphodiesterases in the central nervous system: implications in mood and cognitive disorders.
Ying Xu, Han-Ting Zhang, James M O'Donnell. Handb Exp Pharmacol 2011
77
7

Characterization of cyclic nucleotide phosphodiesterase isoforms associated to isolated cardiac nuclei.
C Lugnier, T Keravis, A Le Bec, O Pauvert, S Proteau, E Rousseau. Biochim Biophys Acta 1999
43
7

New insights from the structure-function analysis of the catalytic region of human platelet phosphodiesterase 3A: a role for the unique 44-amino acid insert.
Su-Hwi Hung, Wei Zhang, Robin A Pixley, Bradford A Jameson, Yu Chu Huang, Roberta F Colman, Robert W Colman. J Biol Chem 2006
8
12


Natriuretic peptides increase beta1-adrenoceptor signalling in failing hearts through phosphodiesterase 3 inhibition.
Eirik Qvigstad, Lise R Moltzau, Jan Magnus Aronsen, Cam H T Nguyen, Karina Hougen, Ivar Sjaastad, Finn Olav Levy, Tor Skomedal, Jan-Bjørn Osnes. Cardiovasc Res 2010
43
7


Olprinone, a PDE3 inhibitor, modulates the inflammation associated with myocardial ischemia-reperfusion injury in rats.
Rosanna Di Paola, Emanuela Mazzon, Irene Paterniti, Daniela Impellizzeri, Placido Bramanti, Salvatore Cuzzocrea. Eur J Pharmacol 2011
20
7

Protein kinase A phosphorylation of human phosphodiesterase 3B promotes 14-3-3 protein binding and inhibits phosphatase-catalyzed inactivation.
Daniel Palmer, Sandra L Jimmo, Daniel R Raymond, Lindsay S Wilson, Rhonda L Carter, Donald H Maurice. J Biol Chem 2007
38
7

From PDE3B to the regulation of energy homeostasis.
Eva Degerman, Faiyaz Ahmad, Youn Wook Chung, Emilia Guirguis, Bilal Omar, Lena Stenson, Vincent Manganiello. Curr Opin Pharmacol 2011
72
7

Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
Marion A H Feijge, Karin Ansink, Kristof Vanschoonbeek, Johan W M Heemskerk. Biochem Pharmacol 2004
57
7

PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects.
Enrico Patrucco, Antonella Notte, Laura Barberis, Giulio Selvetella, Angelo Maffei, Mara Brancaccio, Stefano Marengo, Giovanni Russo, Ornella Azzolino, Sergei D Rybalkin,[...]. Cell 2004
360
7

A phosphodiesterase 3B-based signaling complex integrates exchange protein activated by cAMP 1 and phosphatidylinositol 3-kinase signals in human arterial endothelial cells.
Lindsay S Wilson, George S Baillie, Lisa M Pritchard, Bibiana Umana, Anna Terrin, Manuela Zaccolo, Miles D Houslay, Donald H Maurice. J Biol Chem 2011
40
7

Distinctive anatomical patterns of gene expression for cGMP-inhibited cyclic nucleotide phosphodiesterases.
R R Reinhardt, E Chin, J Zhou, M Taira, T Murata, V C Manganiello, C A Bondy. J Clin Invest 1995
140
7

Cyclic nucleotide phosphodiesterase activity, expression, and targeting in cells of the cardiovascular system.
Donald H Maurice, Daniel Palmer, Douglas G Tilley, Heather A Dunkerley, Stuart J Netherton, Daniel R Raymond, Hisham S Elbatarny, Sandra L Jimmo. Mol Pharmacol 2003
239
7

Phosphodiesterase inhibition in heart failure.
Matthew Movsesian, Josef Stehlik, Fabrice Vandeput, Michael R Bristow. Heart Fail Rev 2009
45
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.